Effects of pegaptanib injections on intraocular pressure with and without anterior chamber paracentesis: A Prospective Study

Acta Ophthalmologica

Volumn 90, Issue 3, 2012, Pages 254-258

  Knip, Maria M ^a   Välimäki, Juha ^a  

^a Department of Ophthalmology   (Finland)

Author keywords

AMD; anti VEGF; aqueous tap; intravitreal injections; IOP; macugen; paracentesis; pegabtanib; VEGF inhibitor

Indexed keywords

PEGAPTANIB;

AGED; ANTERIOR CHAMBER PARACENTESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EYE PAIN; EYE SURGERY; FEMALE; HUMAN; INJECTION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; PARACENTESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; ANGIOGENESIS INHIBITORS; ANTERIOR CHAMBER; APTAMERS, NUCLEOTIDE; EYE PAIN; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MALE; PAIN MEASUREMENT; PARACENTESIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860487905     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01904.x     Document Type: Article

References (35)

1. Aiello L, Brucker A, Chang S, et al., (2004): Evolving guidelines for intravitreous injections. Retina 24 (Suppl.): S3-S9.
2. Avery R, Pieramici D, Rabena M, et al., (2006): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363-372.
3. Azuara-Blanco A, &, Katz J, (1997): Infectious keratitis in a paracentesis tract. Ophthalmic Surg Lasers 28: 332-333.
4. Bakri SJ, Pulido JS, McCannel CA, et al., (2007): Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 10 [Epub ahead of print].
5. Benz M, Albini T, Holz E, et al., (2006): Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113: 1174-1178. (Pubitemid 43947221)
6. Chew E, Trope G, &, Mitchell B, (1987): Diurnal pressure variation in young adults with central retinal vein occlusion. Ophthalmology 94: 1545-1549. (Pubitemid 18006880)
7. Chui W-S, Lam A, Chen D, &, Chiu R, (2008): The influence of corneal properties on rebound tonometry. Ophthalmology 115: 80-84. (Pubitemid 350309417)
8. Coden D, Freeman W, &, Weinreb R, (1988): Intraocular pressure response after pneumatic retinopexy. Ophthalmic Surg 19: 667-669.
9. Falkenstein I, Cheng L, &, Freeman W, (2007): Changes in intraocular pressure after intravitreal injection of bevacizumab (Avastin). Retina 27: 1044-1047. (Pubitemid 350304005)
10. Fernandes P, Díaz-Rey J, Queirõs A, et al., (2005): Comparison of the ICareÂ" rebound tonometer with the Goldmann tonometer in a normal population. Ophthal Physiol Opt 25: 436-440. (Pubitemid 41710978)
11. Fleiss JL, Levin B, &, Cho Paik M, Statistical methods for rates and proportions, 3rd edn. Wiley, New York, 2003, Table A.4, 660-683.
12. Frenkel RE, Mani L, Toler AR, &, Frenkel MP, (2007): Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma. Am J Ophthalmol 143: 1034-1035. (Pubitemid 46764645)
13. Hariprasad S, Shah G, &, Blinder K, (2006): Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol 141: 200-201. (Pubitemid 43016199)
14. Hartnett M, Weiter J, Staurenghi G, &, Elsner A, (1996): Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103: 2042-2053. (Pubitemid 27024625)
15. Helbig H, Noske W, Kleineidam M, et al., (1995): Bacterial endophthalmitis after anterior chamber paracentesis. Br J Ophthalmol 79: 866.
16. Hernaez-Ortega M, &, Soto-Pedre E, (2008): Intravitreal injection of trimcinolone acetonide and intraocular pressure. Acta Ophthalmol 86:693.
17. Hollands H, Wong J, Bruen R, et al., (2006): Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 42: 807-811.
18. Jager R, Aiello L, Patel S, &, Cunningham E, (2004): Risks of intravitreous injection: a comprehensive review. Retina 24: 676-698. (Pubitemid 39391758)
19. Joondeph B, &, Joondeph H, (1986): Purulent anterior segment endophthalmitis following anterior chamber paracentesis. Ophthalmic Surg 17: 91-93. (Pubitemid 16130790)
20. Kontiola AI, (2000): A new induction-based impact method for measuring intraocular pressure. Acta Ophtahalmol Scand 78: 142-145. (Pubitemid 30201419)
21. Kotliar K, Maier M, Bauer S, et al., (2007): Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomedical model. Acta Ophthalmol Scand 85: 777-781. (Pubitemid 47616796)
22. Kourlas H, &, Schiller D, (2006): Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: A review. Clin Ther 28: 36-44. (Pubitemid 43254988)
23. Lam D, Chua J, Tham C, &, Lai C, (2002): Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma. A pilot study. Ophthalmology 109: 64-70. (Pubitemid 34027425)
24. Lin J-M, Tsai Y-Y, Chiu Y-T, &, Hung P-T, (2006): Paracentesis before or after intravitreal injection of triamcinolone acetonide and its necessity? Am J Ophthalmol 141: 985.
25. Martinez-de-la-Casa J, Garcia-Feijoo J, Castillo A, &, Garcia-Sanchez J, (2005): Reproducibility and clinical evaluation of rebound tonometry. Invest Ophthalmol Vis Sci 46: 4578-4780.
26. Michelson G, Groh M, &, Langhans M, (1996): Perfusion of the juxtapapillary reina and the optic nerve head in acute ocular hypertension. Ger J Opthalmol 5: 315-321.
27. Pakrou N, Gary T, Mills RJ, et al., (2008): Clinical comparison of the Icare tonometer and Goldmann applanation tonometry. J Glaucoma 17: 43-47. (Pubitemid 351321476)
28. Riva C, Hero M, Titze P, &, Petrig B, (1997): Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graef's Arch Clin Exp Ophthalmol 235: 618-626. (Pubitemid 27450378)
29. Rosenfeld P, Brown D, Heier J, et al., & for the MARINA study group. (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431. (Pubitemid 44511557)
30. Schulte K, Wolf S, Arend O, et al., (1996): Retinal hemodynamics during increased intraocular pressure. Ger J Ophthalmol 5: 1-5.
31. Van der Lelij A, &, Rothova A, (1997): Diagnostic anterior chamber paracentesis in uveitis: a safe procedure? Br J Ophthalmol 81: 976-979. (Pubitemid 27493985)
32. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N) Clinical Trial Group (2006a): Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113: 992-1001.
33. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group (2006b): Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113: 1508-1521.
34. Von Hanno T, Kinge B, &, Fossen K, (2009): Retinal artery occlusion following intreavitreal anti-VEGF therapy. Acta Ophthalmol [Epub ahead of print].
35. Yan D, Coloma F, Metheentrairut A, et al., (1994): Deformation of the lamina cribrosa by elevated intraocular pressure. Br J Ophthalmol 78: 643-648. (Pubitemid 24249163)